Literature DB >> 29025996

Structure of the TAPBPR-MHC I complex defines the mechanism of peptide loading and editing.

Christoph Thomas1, Robert Tampé1,2.   

Abstract

Adaptive immunity is shaped by a selection of peptides presented on major histocompatibility complex class I (MHC I) molecules. The chaperones Tapasin (Tsn) and TAP-binding protein-related (TAPBPR) facilitate MHC I peptide loading and high-affinity epitope selection. Despite the pivotal role of Tsn and TAPBPR in controlling the hierarchical immune response, their catalytic mechanism remains unknown. Here, we present the x-ray structure of the TAPBPR-MHC I complex, which delineates the central step of catalysis. TAPBPR functions as peptide selector by remodeling the MHC I α2-1-helix region, stabilizing the empty binding groove, and inserting a loop into the groove that interferes with peptide binding. The complex explains how mutations in MHC I-specific chaperones cause defects in antigen processing and suggests a unifying mechanism of peptide proofreading.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29025996     DOI: 10.1126/science.aao6001

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  45 in total

1.  Utilizing TAPBPR to promote exogenous peptide loading onto cell surface MHC I molecules.

Authors:  F Tudor Ilca; Andreas Neerincx; Mark R Wills; Maike de la Roche; Louise H Boyle
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-13       Impact factor: 11.205

2.  Metal-triggered conformational reorientation of a self-peptide bound to a disease-associated HLA-B*27 subtype.

Authors:  Ronja Driller; Martin Ballaschk; Peter Schmieder; Barbara Uchanska-Ziegler; Andreas Ziegler; Bernhard Loll
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

3.  Production of soluble pMHC-I molecules in mammalian cells using the molecular chaperone TAPBPR.

Authors:  Sara M O'Rourke; Giora I Morozov; Jacob T Roberts; Adam W Barb; Nikolaos G Sgourakis
Journal:  Protein Eng Des Sel       Date:  2019-12-31       Impact factor: 1.650

Review 4.  A personal retrospective on the mechanisms of antigen processing.

Authors:  Peter Cresswell
Journal:  Immunogenetics       Date:  2019-01-29       Impact factor: 2.846

5.  Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity.

Authors:  Brogan Yarzabek; Anita J Zaitouna; Eli Olson; Gayathri N Silva; Jie Geng; Aviva Geretz; Rasmi Thomas; Sujatha Krishnakumar; Daniel S Ramon; Malini Raghavan
Journal:  Elife       Date:  2018-07-10       Impact factor: 8.140

6.  Structure and Peptidome of the Bat MHC Class I Molecule Reveal a Novel Mechanism Leading to High-Affinity Peptide Binding.

Authors:  Zehui Qu; Zibin Li; Lizhen Ma; Xiaohui Wei; Lijie Zhang; Ruiying Liang; Geng Meng; Nianzhi Zhang; Chun Xia
Journal:  J Immunol       Date:  2019-05-10       Impact factor: 5.422

Review 7.  Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway.

Authors:  Kannan Natarajan; Jiansheng Jiang; David H Margulies
Journal:  Crit Rev Biochem Mol Biol       Date:  2019-05-14       Impact factor: 8.250

8.  Endoplasmic reticulum chaperones stabilize ligand-receptive MR1 molecules for efficient presentation of metabolite antigens.

Authors:  Hamish E G McWilliam; Jeffrey Y W Mak; Wael Awad; Matthew Zorkau; Sebastian Cruz-Gomez; Hui Jing Lim; Yuting Yan; Sam Wormald; Laura F Dagley; Sidonia B G Eckle; Alexandra J Corbett; Haiyin Liu; Shihan Li; Scott J J Reddiex; Justine D Mintern; Ligong Liu; James McCluskey; Jamie Rossjohn; David P Fairlie; Jose A Villadangos
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

9.  Tumor-associated calreticulin variants functionally compromise the peptide loading complex and impair its recruitment of MHC-I.

Authors:  Najla Arshad; Peter Cresswell
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

Review 10.  What to do with HLA-DO/H-2O two decades later?

Authors:  Robin Welsh; Nianbin Song; Scheherazade Sadegh-Nasseri
Journal:  Immunogenetics       Date:  2019-01-26       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.